Item | Tumor group (n = 43) | Non-tumor group (n = 18) | ||||||||||
Anemia group (n = 33) | Non-anemia group (n = 10) | Anemia group (n = 9) | Non-anemia group (n = 9) | |||||||||
Before treatment | After treatment | t | Before treatment | After treatment | t | Before treatment | After treatment | t | Before treatment | After treatment | t | |
Hb (g/L) | 85.45 ± 18.33 | 91.18 ± 15.91 | 1.9711* | 122.80 ± 7.08 | 118.40 ± 11.47 | 1.0320 | 81.33 ± 39.04 | 84.44 ± 37.27 | 0.1729 | 123.78 ± 47.34 | 118.33 ± 47.17 | 0.2446 |
BMP6 (mg/ml) | 172.60 ± 99.80 | 167.76 ± 94.00 | 0.1838 | 155.74 ± 47.10 | 151.42 ± 37.48 | 0.2270 | 177.74 ± 77.69 | 171.96 ± 88.19 | 0.1312 | 117.69 ± 59.17 | 119.69 ± 59.17 | 0.0480 |
Hepcidin (mg/L) | 1.09 ± 0.41 | 0.73 ± 0.45 | 3.3941# | 1.07 ± 0.32 | 1.07 ± 0.33 | 0.0010 | 0.89 ± 0.52 | 0.80 ± 0.51 | 0.3721 | 79 ± 0.41 | 0.84 ± 0.48 | 0.2240 |
IL-6 (mg/ml) | 50.76 ± 42.10 | 30.33 ± 28.39 | 2.3597* | 37.57 ± 45.37 | 25.29 ± 18.92 | 1.4334 | 19.01 ± 15.72 | 19.72 ± 812.4 | 0.0809 | 14.41 ± 12.60 | 39.64 ± 7.45 | 1.6015 |